Tofacitinib Reduces Spinal Inflammation in Vertebral Bodies and Posterolateral Elements in Ankylosing Spondylitis: Results from a Phase 2 Trial
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Tofacitinib Reduces Spinal Inflammation in Vertebral Bodies and Posterolateral Elements in Ankylosing Spondylitis: Results from a Phase 2 Trial ; volume:10 ; number:4 ; day:18 ; month:6 ; year:2023 ; pages:1001-1020 ; date:8.2023
Rheumatology and therapy ; 10, Heft 4 (18.6.2023), 1001-1020, 8.2023
- Urheber
-
Østergaard, Mikkel
Wu, Joseph
Fallon, Lara
Sherlock, Sarah P.
Wang, Cunshan
Fleishaker, Dona
Kanik, Keith S.
Maksymowych, Walter P.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40744-023-00564-y
- URN
-
urn:nbn:de:101:1-2023100509040652817157
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Østergaard, Mikkel
- Wu, Joseph
- Fallon, Lara
- Sherlock, Sarah P.
- Wang, Cunshan
- Fleishaker, Dona
- Kanik, Keith S.
- Maksymowych, Walter P.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Incidence and predictors of morphometric vertebral fractures in patients with ankylosing spondylitis
Integrated safety analysis of tofacitinib from Phase 2 and 3 trials of patients with ankylosing spondylitis
Andersson lesion in ankylosing spondylitis
Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis or Ankylosing Spondylitis by Cigarette Smoking Status
Surgical treatment of ankylosing spondylitis deformity
Secukinumab: A Review in Ankylosing Spondylitis
Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?
Pain and Inflammation as Mediators of Tofacitinib Treatment Effect on Fatigue in Patients with Ankylosing Spondylitis: A Mediation Analysis
ANKHvariants associated with ankylosing spondylitis: gender differences
Association between ankylosing spondylitis and m6A methylation
Atherosclerosis in Egyptian patients with ankylosing spondylitis
Developing mapping algorithms to predict EQ-5D health utility values from Bath Ankylosing Spondylitis Disease Activity Index and Bath Ankylosing Spondylitis Functional Index among patients with Ankylosing Spondylitis
Incidence and predictors of morphometric vertebral fractures in patients with ankylosing spondylitis
Integrated safety analysis of tofacitinib from Phase 2 and 3 trials of patients with ankylosing spondylitis
Andersson lesion in ankylosing spondylitis
Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis or Ankylosing Spondylitis by Cigarette Smoking Status
Surgical treatment of ankylosing spondylitis deformity
Secukinumab: A Review in Ankylosing Spondylitis
Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?
Pain and Inflammation as Mediators of Tofacitinib Treatment Effect on Fatigue in Patients with Ankylosing Spondylitis: A Mediation Analysis
ANKHvariants associated with ankylosing spondylitis: gender differences
Association between ankylosing spondylitis and m6A methylation
Atherosclerosis in Egyptian patients with ankylosing spondylitis
Developing mapping algorithms to predict EQ-5D health utility values from Bath Ankylosing Spondylitis Disease Activity Index and Bath Ankylosing Spondylitis Functional Index among patients with Ankylosing Spondylitis
Incidence and predictors of morphometric vertebral fractures in patients with ankylosing spondylitis
Integrated safety analysis of tofacitinib from Phase 2 and 3 trials of patients with ankylosing spondylitis
Andersson lesion in ankylosing spondylitis
Efficacy and Safety of Tofacitinib in Patients with Psoriatic Arthritis or Ankylosing Spondylitis by Cigarette Smoking Status
Surgical treatment of ankylosing spondylitis deformity
Secukinumab: A Review in Ankylosing Spondylitis
Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?
Pain and Inflammation as Mediators of Tofacitinib Treatment Effect on Fatigue in Patients with Ankylosing Spondylitis: A Mediation Analysis
ANKHvariants associated with ankylosing spondylitis: gender differences
Association between ankylosing spondylitis and m6A methylation
Atherosclerosis in Egyptian patients with ankylosing spondylitis